VEGFA and neoplasm: The finding that a number of malignant human tumors, including lung, breast, gastrointestinal tract, ovary, and colon, produce VEGF [4-8], and that the inhibition of VEGF-induced angiogenesis significantly inhibits tumor growth in vivo[9], point to its possessing clinical significance in tumor growth.